Perspectives and Challenges of Antioxidant Therapy for Atrial Fibrillation

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 2016 Dec 1

PMID 27900409

Citations 21

Authors

Iveta Gasparova

Peter Kubatka

Radka Opatrilova

Martin Caprnda

Slavomira Filipova

Luis Rodrigo

Leone Malan

Ioana Mozos

Miroslava Rabajdova

Vladimir Nosal

Nazarii Kobyliak

Vanda Valentova

Daniel Petrovic

Mariusz Adamek

Peter Kruzliak

Affiliations

Soon will be listed here.

Abstract

Atrial fibrillation (AF) is the most common sustained arrhythmia associated with significant morbidity and mortality. The mechanisms underlying the pathogenesis of AF are poorly understood, although electrophysiological remodeling has been described as an important initiating step. There is growing evidence that oxidative stress is involved in the pathogenesis of AF. Many known triggers of oxidative stress, such as age, diabetes, smoking, and inflammation, are linked with an increased risk of arrhythmia. Numerous preclinical studies and clinical trials reported the importance of antioxidant therapy in the prevention of AF, using vitamins C and E, polyunsaturated fatty acids, statins, or nitric oxide donors. The aim of our work is to give a current overview and analysis of opportunities, challenges, and benefits of antioxidant therapy in AF.

Citing Articles

Multimodality Imaging in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation.

Chung H, Choi E Diagnostics (Basel). 2023; 13(19).

PMID: 37835790 PMC: 10572439. DOI: 10.3390/diagnostics13193049.

Accuracy of attenuation coefficient measurement (ACM) for real-time ultrasound hepatic steatometry: Comparison of simulator/phantom data with magnetic resonance imaging proton density fat fraction (MRI-PDFF).

Kobyliak N, Dynnyk O, Savytska M, Solodovnyk O, Zakomornyi O, Omelchenko O Heliyon. 2023; 9(10):e20642.

PMID: 37818006 PMC: 10560839. DOI: 10.1016/j.heliyon.2023.e20642.

Resveratrol Effects on the Reproductive System in Ovariectomized Rats: Deciphering Possible Mechanisms.

Zaychenko G, Stryga O, Sinitsyna O, Doroshenko A, Sulaieva O, Falalyeyeva T Molecules. 2022; 27(15).

PMID: 35956866 PMC: 9370311. DOI: 10.3390/molecules27154916.

Antioxidants in Arrhythmia Treatment-Still a Controversy? A Review of Selected Clinical and Laboratory Research.

Szyller J, Jagielski D, Bil-Lula I Antioxidants (Basel). 2022; 11(6).

PMID: 35740006 PMC: 9220256. DOI: 10.3390/antiox11061109.

Association Between Atrial Fibrillation and the Risk of Cardiovascular Mortality Among Elderly Adults With Ischemic Stroke in Northeast China: A Community-Based Prospective Study.

Xia Z, Dang W, Jiang Y, Liu S, Yue L, Jia F Front Aging Neurosci. 2022; 14:836425.

PMID: 35360217 PMC: 8961322. DOI: 10.3389/fnagi.2022.836425.

References

Kubatka P, Stollarova N, Skarda J, Zihlavnikova K, Kajo K, Kapinova A . Preventive effects of fluvastatin in rat mammary carcinogenesis. Eur J Cancer Prev. 2012; 22(4):352-7. DOI: 10.1097/CEJ.0b013e32835b385d. View

Amar D, Zhang H, Heerdt P, Park B, Fleisher M, Thaler H . Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein. Chest. 2005; 128(5):3421-7. DOI: 10.1378/chest.128.5.3421. View

Vest J, Wehrens X, Reiken S, Lehnart S, Dobrev D, Chandra P . Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation. 2005; 111(16):2025-32. DOI: 10.1161/01.CIR.0000162461.67140.4C. View

Planavila A, Laguna J, Vazquez-Carrera M . Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy by preventing nuclear factor-kappa B activation. Biochim Biophys Acta. 2005; 1687(1-3):76-83. DOI: 10.1016/j.bbalip.2004.11.004. View

Kannel W, Wolf P, Benjamin E, Levy D . Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998; 82(8A):2N-9N. DOI: 10.1016/s0002-9149(98)00583-9. View

Lip G, Kakar P, Watson T . Atrial fibrillation--the growing epidemic. Heart. 2007; 93(5):542-3. PMC: 1955544. DOI: 10.1136/hrt.2006.110791. View

Savelieva I, Kourliouros A, Camm J . Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance. Naunyn Schmiedebergs Arch Pharmacol. 2009; 381(3):1-13. DOI: 10.1007/s00210-009-0468-y. View

Wang , Takeda , Mochizuki , Jindal , Dhalla . Mechanisms of Hydrogen Peroxide-Induced Increase in Intracellular Calcium in Cardiomyocytes. J Cardiovasc Pharmacol Ther. 2000; 4(1):41-48. DOI: 10.1177/107424849900400107. View

Dehghani M, Kasianzadeh M, Rezaei Y, Sepehrvand N . Atorvastatin Reduces the Incidence of Postoperative Atrial Fibrillation in Statin-Naive Patients Undergoing Isolated Heart Valve Surgery: A Double-Blind, Placebo-Controlled Randomized Trial. J Cardiovasc Pharmacol Ther. 2014; 20(5):465-72. DOI: 10.1177/1074248414564869. View

10.

Argmann C, Edwards J, Sawyez C, ONeil C, Hegele R, Pickering J . Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux. J Biol Chem. 2005; 280(23):22212-21. DOI: 10.1074/jbc.M502761200. View

11.

Qi X, Yeh Y, Xiao L, Burstein B, Maguy A, Chartier D . Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current. Circ Res. 2008; 103(8):845-54. DOI: 10.1161/CIRCRESAHA.108.175463. View

12.

Patti G, Chello M, Candura D, Pasceri V, DAmbrosio A, Covino E . Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation. 2006; 114(14):1455-61. DOI: 10.1161/CIRCULATIONAHA.106.621763. View

13.

Van Wagoner D, Pond A, McCarthy P, Trimmer J, Nerbonne J . Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res. 1997; 80(6):772-81. DOI: 10.1161/01.res.80.6.772. View

14.

Milei J, Forcada P, Fraga C, Grana D, Iannelli G, Chiariello M . Relationship between oxidative stress, lipid peroxidation, and ultrastructural damage in patients with coronary artery disease undergoing cardioplegic arrest/reperfusion. Cardiovasc Res. 2007; 73(4):710-9. DOI: 10.1016/j.cardiores.2006.12.007. View

15.

Sisto T, Paajanen H, Harmoinen A, Nordback I, Tarkka M . Pretreatment with antioxidants and allopurinol diminishes cardiac onset events in coronary artery bypass grafting. Ann Thorac Surg. 1995; 59(6):1519-23. DOI: 10.1016/0003-4975(95)00197-s. View

16.

Korantzopoulos P, Kolettis T, Kountouris E, Dimitroula V, Karanikis P, Pappa E . Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. Int J Cardiol. 2005; 102(2):321-6. DOI: 10.1016/j.ijcard.2004.12.041. View

17.

Simon J, Duglan D, Casadei B, Carnicer R . Nitric oxide synthase regulation of cardiac excitation-contraction coupling in health and disease. J Mol Cell Cardiol. 2014; 73:80-91. DOI: 10.1016/j.yjmcc.2014.03.004. View

18.

Farquharson A, Metcalf R, Sanders P, Stuklis R, Edwards J, Gibson R . Effect of dietary fish oil on atrial fibrillation after cardiac surgery. Am J Cardiol. 2011; 108(6):851-6. DOI: 10.1016/j.amjcard.2011.04.036. View

19.

Yue T, McKenna P, Gu J, Cheng H, Ruffolo Jr R, Feuerstein G . Carvedilol, a new vasodilating beta adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine-xanthine oxidase and neutrophils. Cardiovasc Res. 1994; 28(3):400-6. DOI: 10.1093/cvr/28.3.400. View

20.

Hidalgo C, Donoso P, Carrasco M . The ryanodine receptors Ca2+ release channels: cellular redox sensors?. IUBMB Life. 2005; 57(4-5):315-22. DOI: 10.1080/15216540500092328. View